Skip to main content
In stock|Targeted Therapy (Investigational)

Telaglenastat

Oncology TypeSolid Tumour
Drug Class / MechanismMetabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)
No Image
Description

Telaglenastat is classified as a Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase), sourced for use within our Targeted Therapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy (Investigational)
Oncology TypeSolid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3